Recombinant
RabMAb

Anti-ICOS antibody [SP98] (ab105227)

Publishing research using ab105227? Please let us know so that we can cite the reference in this datasheet.

ab105227 has been referenced in 4 publications.

  • Hurabielle C  et al. Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients. Hum Pathol 71:100-108 (2018). IHC-P ; Human . PubMed: 29107664
  • Le KS  et al. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy. Cancer Res 76:4648-60 (2016). PubMed: 27246829
  • Song Y  et al. Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma. J Thorac Dis 8:314-22 (2016). IHC-P ; Human . PubMed: 27076925
  • Zhang Y  et al. The clinical impact of ICOS signal in colorectal cancer patients. Oncoimmunology 5:e1141857 (2016). IHC . PubMed: 27467961

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up